0001646606-19-000002.txt : 20190619 0001646606-19-000002.hdr.sgml : 20190619 20190619160209 ACCESSION NUMBER: 0001646606-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190619 DATE AS OF CHANGE: 20190619 EFFECTIVENESS DATE: 20190619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoMolecular Therapeutics, Inc. CENTRAL INDEX KEY: 0001646606 IRS NUMBER: 472787642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-342324 FILM NUMBER: 19906086 BUSINESS ADDRESS: STREET 1: 3513 BRIGHTON BOULEVARD STREET 2: SUITE 431 CITY: DENVER STATE: CO ZIP: 80216 BUSINESS PHONE: (303) 544-2104 MAIL ADDRESS: STREET 1: 3513 BRIGHTON BOULEVARD STREET 2: SUITE 431 CITY: DENVER STATE: CO ZIP: 80216 FORMER COMPANY: FORMER CONFORMED NAME: ImmunoMolecular Therapeutics, LLC DATE OF NAME CHANGE: 20150629 D 1 primary_doc.xml X0708 D LIVE 0001646606 ImmunoMolecular Therapeutics, Inc. 3513 BRIGHTON BOULEVARD SUITE 431 DENVER CO COLORADO 80216 (303) 544-2104 DELAWARE ImmunoMolecular Therapeutics, LLC Corporation true 2015 Peter Gottlieb 3513 Brighton Boulevard Suite 431 Denver CO COLORADO 80216 Executive Officer Director Promoter Ed Orr 3513 Brighton Boulevard Suite 431 Denver CO COLORADO 80216 Director Promoter Jonathan Behr 3513 Brighton Boulevard Suite 431 Denver CO COLORADO 80216 Director Jason Dinges 3513 Brighton Boulevard Suite 431 Denver CO COLORADO 80216 Director Aaron Michels 3513 Brighton Boulevard Suite 431 Denver CO COLORADO 80216 Promoter Biotechnology Decline to Disclose 06b false 2019-06-04 false true false 0 9999985 2999992 6999993 false 7 0 0 0 false ImmunoMolecular Therapeutics, Inc. Peter Gottlieb Peter Gottlieb Chief Executive Officer 2019-06-17